跳转至内容
Merck

11493027001

Roche

IsoStrip小鼠单克隆抗体分型试剂盒

sufficient for 10 tests

别名:

杂交瘤亚型分型

登录查看公司和协议定价


About This Item

分類程式碼代碼:
23201100

用途

sufficient for 10 tests

品質等級

製造商/商標名

Roche

儲存溫度

2-8°C

一般說明

IsoStrip小鼠单克隆抗体分型试剂盒是一个简单的三步法试剂盒,可用于快速鉴定小鼠单克隆抗体。

内容物
  • 显影管,含有预先包被抗小鼠Ig抗体的冻干乳胶珠
  • 分型试纸条,预先包被亚类和轻链特异性抗小鼠Ig抗体

特異性

与乳胶珠结合的抗小鼠抗体将与任意同种型的小鼠单克隆抗体反应。试纸条上固定的山羊抗小鼠抗体,能与各种常见的小鼠抗体同种型(IgG1、IgG2a、IgG2b、IgG3、IgM和IgA)以及轻链发生特异性结合。

浓度为1.0 μg/ml时,对所有特异性抗体(IgML除外)的特异性:≥ 2
IgM Lambda, 浓度为1.0 μg/ml时:≥ 1

應用

该试剂盒可用于快速鉴定小鼠单克隆抗体(免疫球蛋白)的分类、亚类和轻链类型。

特點和優勢

  • 可靠:产生与标准ELISA测定相当的结果
  • 快速:从开始到结束仅需5分钟
  • 轻松:仅需3个步骤
  • 经济:无需任何设备或其他试剂
  • 高度特异性:与FBS无交叉反应

包裝

1个试剂盒包含2种组分。

規格

测定时间:5分钟
样品材料:杂交瘤上清液,纯化小鼠单克隆抗体,腹水

準備報告

工作溶液:稀释样品
  • 从罐中取出所需数量的分型试纸条。取下相同数量的显影管的盖子。
    可以用铅笔或实验室记号笔标记显影管,方便识别。
  • 使用1% BSA/磷酸盐缓冲盐水(PBS)稀释含有小鼠单克隆抗体的样品,pH 7.2至7.6。
    培养上清液样品应以1:10至1:100稀释。腹水样品应按1:20,000稀释。这些是推荐稀释度,具体取决于样品中的抗体浓度。根据我们的经验,稀释样品的单克隆抗体
    浓度为0.1至1 g/ml时可获得最佳结果。将150ml上述稀释样品加入显影管中。

其他說明

仅用于生命科学研究。不可用于诊断。

法律資訊

IsoStrip is a trademark of Roche

仅试剂盒组分

产品编号
说明

  • Development Tubes, containing lyophilized latex beads, precoated with anti-mouse-Ig antibodies

  • Isotyping Strips, precoated with subclass- and light-chain-specific anti-mouse-Ig antibodies

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

nwg

閃點(°F)

does not flash

閃點(°C)

does not flash


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 1

1 of 1

Wioleta M Zelek et al.
Frontiers in immunology, 11, 612402-612402 (2021-01-12)
Better understanding of roles of complement in pathology has fuelled an explosion of interest in complement-targeted therapeutics. The C5-blocking monoclonal antibody (mAb) eculizumab, the first of the new wave of complement blocking drugs, was FDA approved for treatment of Paroxysmal
Julie A Webster et al.
Cancers, 13(12) (2021-07-03)
The current endoscopy and biopsy diagnosis of esophageal adenocarcinoma (EAC) and its premalignant condition Barrett's esophagus (BE) is not cost-effective. To enable EAC screening and patient triaging for endoscopy, we developed a microfluidic lectin immunoassay, the EndoScreen Chip, which allows
Jisheng Lin et al.
Clinical and vaccine immunology : CVI, 23(8), 681-688 (2016-06-10)
There is a significant need for an effective multivalent Shigella vaccine that targets the most prevalent serotypes. Most Shigella vaccines under development utilize serotype-specific lipopolysaccharides (LPSs) as a major component based on protection and epidemiological data. As vaccine formulations advance
Wioleta M Zelek et al.
Immunology, 157(4), 283-295 (2019-05-24)
Over the last decade there has been an explosion in complement therapies; one-third of the drugs in the clinic or in development target C5 protein. Eculizumab, a monoclonal antibody (mAb) that binds C5 and blocks its cleavage by the convertase
Floriane Etienne et al.
Frontiers in oncology, 10, 20-20 (2020-03-03)
Antibodies directed against CD22 have been used in radioimmunotherapy (RIT) clinical trials to treat patients with diffuse large B-cell lymphoma (DLBCL) with promising results. However, relevant preclinical models are needed to facilitate the evaluation and optimization of new protocols. Spontaneous

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门